Key result
Egualen sodium cuts aspirin-induced small intestinal mucosal injuries by ~70%.
Why the study?
Therapeutic strategies for patients with low-dose aspirin-induced small intestinal injury have not been determined.
Does egualen sodium prevent small-intestinal mucosal damage induced by low-dose aspirin in healthy adult male volunteers?
RCT (n=20)
Open-label
Simple fixed-allocation randomization using a block-randomization scheme
No
Does egualen sodium prevent small-intestinal mucosal damage induced by low-dose aspirin in healthy adult male volunteers?
Daily use of 30 mg of egualen sodium shows a preventative effect on low-dose aspirin-induced small intestinal injury in healthy volunteers.
Answers are grounded in this paper and cite their sources.
Egualen sodium prevented low-dose aspirin-induced small intestinal injury in healthy volunteers; leaves open benefit in patients on chronic therapy.
Low-dose aspirin, which is widely used to reduce the risk of cardio- and cerebrovascular thrombosis, often induces gastroenteropathy by increasing the permeability of the mucosa. However, therapeutic strategies for patients with low-dose aspirin-induced small intestinal injury have not been determined. We evaluated the preventative effect of egualen sodium hydrate, a gastro-protective agent that suppresses indomethacin-induced small-intestinal damage in rats, against small-intestinal mucosal damage induced by low-dose aspirin in healthy adult male volunteers. Participants were randomly allocated to receive aspirin 100 mg/kg daily (control group, n = 10) or aspirin 100 mg/kg plus egualen sodium 30 mg daily (egualen sodium group, n = 10). Small intestinal mucosal injury was evaluated by capsule endoscopy two weeks after initiation of drug administration. Fecal analyses (occult blood test, immunochemical test, transferrin measurement and calprotectin measurement) were carried out before and after treatment. Egualen sodium significantly suppressed the total number of small intestinal injuries detected by capsule endoscopy and the positive ratio for the fecal occult blood test. Daily use of 30 mg of egualen sodium showed a preventative effect on low-dose aspirin-induced small intestinal injury. Since acid suppression therapy was reported to exacerbate NSAIDs-induced enteropathy via dysbiosis, egualen sodium may be useful for patients treated with low-dose aspirin.
No takes yet. Share an insight, caveat, or question.
Iguchi et al. (2018) conducted an RCT in Low-dose aspirin-induced small intestinal mucosal damage (n=20). Egualen sodium hydrate vs. Aspirin 100 mg/day alone was evaluated on Total number of small intestinal mucosal injuries detected by capsule endoscopy (p=<0.01). Daily administration of of egualen sodium reduced the total number of small intestinal mucosal injuries induced by low-dose aspirin compared to aspirin alone.
Synapse has enriched 10 related papers. Consider them for comparative context: